APAAACI News & Notes: January/February 2023
Updated: Mar 3
Dear Friends and Colleagues,
Warm greetings from APAAACI!
It is my great pleasure and honor to write to you as the newly elected President of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). I am indeed excited to continue to work with the new APAAACI Board and all of you to advance our mission of promoting excellence in patient care, education, and research in the field of allergy, asthma, and clinical immunology in the Asia Pacific region.
I would like to take this opportunity to extend my sincere gratitude to my predecessor, Prof. Ruby Pawankar for her outstanding leadership, vision and extensive contributions to APAAACI and the region during her presidency. Under her guidance, we have made great strides in advancing APAAACI, not just as a regional but also at a global platform. I am extremely delighted also to announce that Prof. Ruby Pawankar will continue to serve not only in her capacity as the Immediate Past President, but also as the newly elected Executive Director. I am committed to working together with her in building on this foundation moving forward.
We will continue to focus on our priorities of promoting collaboration and networking, education and training, and research and innovation. We will work to foster the development of the next generation of allergy, asthma, and clinical immunology experts, and to support the ongoing professional development of our members.
Thank you for your ongoing support to APAAACI, and we look forward to working with you in the years ahead.
It is my honor to write to you as the Executive Director of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). I would first like to express my deepest gratitude for your unending support in the past years to APAAACI for collaborating with all APAAACI's initiatives that has helped elevate improve the lives of those with allergies, asthma, and clinical immunological diseases across the Asia Pacific region.
In the coming years, I'm extremely delighted to work together, hand in hand with Prof. Jiu Yao Wang and also the APAAACI Board, as we continue to strategize and focus on elaborating the mission of APAAACI in a seamless manner. We are dedicated to advancing the field of allergy, asthma, and clinical immunology in the Asia Pacific region, and beyond to creating a healthier future for all.
We are also excited to announce that together with the Allergy and Clinical Immunology Society of Singapore (ACIS) we will be hosting the APAAACI International Conference 2023, in October 2023. This conference will bring together leading experts from around the world to discuss the latest research and innovations in the field. It is an exciting opportunity to learn from and connect with colleagues, and to advance our collective knowledge and understanding of these health conditions. We encourage all of you to take advantage of the many opportunities for education, collaboration, and professional development that APAAACI offers.
APAAACI International Conference 2023
Allergy, Asthma and clinical immunology professionals, mark your calendars!
The APAAACI International Conference 2023 is coming to Singapore from October 23-26. The theme of the conference is ‘The Innovation, Revolution: Allergy Asthma and Immunology’.
This is an excellent opportunity for you to engage with your peers, learn about the latest developments in the field, and participate in insightful discussions about the future of allergy and clinical immunology.
We are excited to announce that abstract submissions for the conference are now open. If you have a research project, case study, or other work that you would like to present at the conference, this is your chance to share it with a global audience of experts in the field.
Don't miss out on this incredible opportunity to network with your colleagues, share your knowledge, and propel your career forward. Submit your abstract today and become a part of the largest Allergy Asthma and Immunology conference in the Asia Pacific region.
We hope to see you in Singapore in October 2023!
APAAACI Allergy Week 2023
We are pleased to announce that the upcoming APAAACI Allergy Week 2023 will take place from 8th to 14th May 2023. This year, our theme is "One Health One Planet Climate Mitigation and Digital Health" which highlights the important linkages between human health, animal health, and environment, and the critical role of digital health in the management of allergies, asthma, and clinical immunological diseases.
As we mark APAAACI Allergy Week, it is important to remember the importance of taking a holistic approach to healthcare. The One Health One Planet concept emphasizes the interconnectedness of human, animal, and environmental health, and recognizes the impact of climate change on these systems. By promoting sustainable practices and reducing carbon emissions, we can mitigate the negative effects of climate change on health. In addition, the increasing use of digital health tools can help to improve healthcare delivery, disease surveillance, and health promotion in a more efficient and effective manner. As we work towards a healthier future for all, let us remember the power of collaboration and the need for a comprehensive, One Health One Planet approach.
As part of this week-long event, we will be hosting a range of activities and events, including educational sessions, public awareness campaigns, and a special live webinar conducted with global experts in this field. Our goal is to increase awareness of the impact of climate change on allergic diseases and asthma, and to promote the use of digital health tools and technologies to help mitigate climate crisis and to reduce the burden of allergic and life-style diseases.
We invite all our member societies and patient advocates to join us in this important initiative. Let us work together towards a healthier, more sustainable future for all.
We look forward to your participation in APAAACI Allergy Week 2023, and to making a positive impact on the health of our communities.
APAAACI is proud to announce APAAACI CENTERS OF EXCELLENCE (ACE)
We are excited to announce that the application submission is now open for the APAAACI Centers of Excellence (ACE). The ACE is designed to recognize multidisciplinary academic medical institutions/centers in the Asia Pacific region and beyond, that are actively promoting innovation, education, research, and advocacy in allergy, asthma, and clinical immunology.
The ACE will create a platform for researchers and clinicians delivering excellence in education, training, research and patient care in allergy, asthma and clinical immunology.
Merits of becoming an ACE
Opportunity to collaborate with APAAACI on educational programs, resources, committees and congresses
Scientific support in the development and dissemination of publications / educational resources
Cross collaboration with other Centers of Excellence regionally and globally to form international multi-Center projects, joint mentorship, research fellowships
ACE recognition award plaque
APAAACI MASTERCLASS on Addressing the Challenges in Food Allergies and Allergic Rhinitis
We successfully organized another APAAACI MasterClass, on 21st February 2023, with the theme: Addressing the Challenges in Food Allergies and Allergic Rhinitis.
The MasterClass was moderated by our regional expert, Prof. Rommel Lobo (Philippines), with lectures from global & regional leading experts, Prof. Walter G Canonica (Italy), Prof. Marysia Recto (Philippines) & Dr. Mongkhon Sompornrattanaphan (Thailand).
We have received tremendous praise for the excellent presentations and content. The webinar garnered more than 1330 registrations from 69 countries, spanning beyond the region.
Upcoming APAAACI MasterClass on Current updates on Hereditary Angioedema (HAE)
We are delighted to announce the upcoming APAAACI MasterClass which will take place on 29th of March 2023 (Wednesday) from 18:00 – 19:30hrs (SGT/HKT/MYT) on Current updates on Hereditary Angioedema (HAE).
The masterclass will be moderated by Prof. Bernard Thong (Singapore) and it will feature talks by global & regional leading experts, Prof. Marcus Maurer (Germany), Dr. Mohamed Abuzakouk (UAE) and Dr. Philip Li (Hong Kong). The program promises to be an informative and engaging session, with a dynamic panel discussion.
Registration & program details below,
Relaunch of Asia Pacific Allergy (AP Allergy) Journal - New Website and Article Submission Open
We are excited to announce the relaunch of Asia Pacific Allergy (AP Allergy), the official journal of APAAACI in partnership with Wolter Kluwer. The journal has undergone significant changes, including a new Editor-in-Chief Prof. Luo Zhang, new editorial board and a brand-new website with a modern and user-friendly interface. We invite all members to visit the new website at www.asiapacificallergy.com to explore the latest updates, including the submission guidelines, editorial policies, and publication standards. We are also pleased to inform you that first issue of the journal is scheduled to be released in March 2023. As the official journal of APAAACI, AP Allergy serves as a valuable platform for researchers, clinicians, and healthcare professionals in the field of allergy, asthma, and clinical immunology. We are committed to providing our readers with high-quality, peer-reviewed articles that contribute to the advancement of knowledge and the improvement of patient care. We encourage all members to submit their research and scholarly articles for publication in AP Allergy.
Women in STEM at the Inception Meeting of G20 EMPOWER
On the 'International Day of Women and Girls in Science', February 11th, on the first day of Inception Meeting of G20 EMPOWER under the Indian Presidency, Prof. Pawankar who serves as a G20 Empower Advocate spoke at the Main session on empowering Women in STEM. Diversity and Inclusion in STEM is crucial for better creativity, innovation and addressing many global challenges like climate crisis, one health, benefiting all. In light of this, APAAACI will be launching an interdisciplinary forum on Women in STEM.
The Respiratory Effectiveness Group (REG) Summit 2023 We are excited to announce that APAAACI will be collaborating with the Respiratory Effectiveness Group (REG) for their upcoming Regulatory Convergence (REG) summit in 2023. We are thrilled to have the opportunity to collaborate with REG and participate in this important event as a part of EAACI-REG Workshop on the theme Next generation health guidelines: how to integrate RWE & EBM. We believe that this collaboration will foster a deeper understanding of the challenges and opportunities in the field and contribute to the advancement of patient care and outcomes. We look forward to a fruitful collaboration with REG and a successful session at the REG summit in 2023.
22nd Malaysian Congress and Exhibition on Allergy and Immunology 2023
We are pleased to announce that APAAACI will be hosting a symposium at the upcoming MSAI Congress 2023. We look forward to seeing you at the MSAI Congress 2023 and invite you to join us for what promises to be a stimulating and informative symposium and congress.
Program details below,
Thai Asthma Council (TAC) Academic Conference 2023
The Thai Asthma Council will be hosting an Academic Conference 2023 from 23-25 March 2023, in Bangkok. We are thrilled to share that APAAACI will collaborate with TAC to promote and advance the field of allergy and immunology in Thailand and beyond by contributing to the scientific program of this conference.
We hope to see you there!
Please find the program details below,
Invite your friends and colleagues to become a JAAFCA Member
APAAACI expresses its deepest gratitude and congratulates all JAAFCA members especially the steering committee, for their continuous and active contribution to APAAACI. JAAFCA members are the soul of the organization.
Kindly invite your fellow colleagues who are below 45 years to join our JAAFCA Membership. Please share the link below. Sign up link here
Highlights of the Allergy World
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes from an International Survey https://www.jaci-inpractice.org/article/S2213-2198(22)01334-4/fulltext Li PH, Pawankar R, Thong BY, Fok JS, Chantaphakul H, Hide M, Jindal AK, Kang HR, Abdul Latiff AH, Lobo RCM, Munkhbayarlakh S, Nguyen DV, Shyur SD, Zhi Y, Maurer M. J Allergy Clin Immunol Pract. 2022 Dec 27:S2213-2198(22)01334-4. doi: 10.1016/j.jaip.2022.12.021 The skin microbiome in the first year of life and its association with atopic dermatitis Rapin A, Rehbinder EM, Macowan M, Pattaroni C, Carlsen KCL, Harris NL, Jonassen CM, Landrø L, Lossius AH, Nordlund B, Rudi K, Skjerven HO, Staff AC, Söderhäll C, Ubags N, Vettukattil R, Marsland BJ. Allergy. 2023 Feb 13. doi: 10.1111/all.15671. Epub ahead of print. CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium Lee S, Kim Y, Kim YS, Zhang H, Noh M, Kwon YG. Allergy. 2023 Feb 14. doi: 10.1111/all.15674. Epub ahead of print. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis https://www.jaci-global.org/article/S2772-8293(22)00095-9/fulltext Khalid MB, Frischmeyer-Guerrerio PA. J Allergy Clin Immunol Glob. 2023 Feb;2(1):1-13. doi: 10.1016/j.jacig.2022.10.003. Epub 2022 Dec 13. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper Feleszko W, Okarska-Napierała M, Buddingh EP, Bloomfield M, Sediva A, Bautista-Rodriguez C, Brough HA, Eigenmann PA, Eiwegger T, Eljaszewicz A, Eyerich S, Gomez-Casado C, Fraisse A, Janda J, Jiménez-Saiz R, Kallinich T, Krohn IK, Mortz CG, Riggioni C, Sastre J, Sokolowska M, Strzelczyk Z, Untersmayr E, Tramper-Stranders G; Immunology Section and Working Group Infections of the EAACI. Pediatr Allergy Immunol. 2023 Jan;34(1):e13900. doi: 10.1111/pai.13900. Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation From the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) https://www.jaci-inpractice.org/article/s2213-2198(22)00940-0/fulltext Kan AKC, Hui HKS, Li TS, Chiang V, Wong JCY, Chan TS, Kwan IYK, Shum WZ, Yeung MSC, Au EYL, Ho CTK, Lau CS, Li PH. . J Allergy Clin Immunol Pract. 2023 Feb;11(2):474-480.e2. doi: 10.1016/j.jaip.2022.08.052. Epub 2022 Sep 17. Advances and Challenges of the Decade: The Ever-Changing Clinical and Genetic Landscape of Immunodeficiency https://www.jaci-inpractice.org/article/S2213-2198(22)01198-9/fulltext Walter JE, Ziegler JB, Ballow M, Cunningham-Rundles C. J Allergy Clin Immunol Pract. 2023 Jan;11(1):107-115. doi: 10.1016/j.jaip.2022.11.007. Clinical characteristics and outcomes of ocular allergy in Thai children Jongvanitpak R, Vichyanond P, Jirapongsananuruk O, Visitsunthorn N, Pacharn P. Asian Pac J Allergy Immunol. 2022 Dec;40(4):407-413. doi: 10.12932/AP-160519-0564. Development, Validation and Comparison of Artificial Neural Network and Logistic Regression Models Predicting Eosinophilic Chronic Rhinosinusitis With Nasal Polyps Zhou H, Fan W, Qin D, Liu P, Gao Z, Lv H, Zhang W, Xiang R, Xu Y. Allergy Asthma Immunol Res. 2023 Jan;15(1):67-82. doi: 10.4168/aair.2023.15.1.67. The understanding of asthma pathogenesis in the era of precision medicine Hizawa N. Allergol Int. 2023 Jan;72(1):3-10. doi: 10.1016/j.alit.2022.09.001. Epub 2022 Oct 1.
Website Editor: Prof. Bernard Thong Website Co-Editor: Prof. Amir HA Latiff